Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
Implementation Science
Published in: Implementation Science 1/2017

Open Access 01-12-2017 | Systematic review

Health professionals’ views on the barriers and enablers to evidence-based practice for acute stroke care: a systematic review

Authors: Leonard Baatiema, Michael E. Otim, George Mnatzaganian, Ama de-Graft Aikins, Judith Coombes, Shawn Somerset

Published in: Implementation Science | Issue 1/2017

Login to get access

Abstract

Background

Adoption of contemporary evidence-based guidelines for acute stroke management is often delayed due to a range of key enablers and barriers. Recent reviews on such barriers focus mainly on specific acute stroke therapies or generalised stroke care guidelines. This review examined the overall barriers and enablers, as perceived by health professionals which affect how evidence-based practice guidelines (stroke unit care, thrombolysis administration, aspirin usage and decompressive surgery) for acute stroke care are adopted in hospital settings.

Methodology

A systematic search of databases was conducted using MEDLINE, Cumulative Index to Nursing and Allied Health Literature (CINAHL), Embase, PsycINFO, Cochrane Library and AMED (Allied and Complementary Medicine Database from 1990 to 2016. The population of interest included health professionals working clinically or in roles responsible for acute stroke care. There were no restrictions to the study designs. A quality appraisal tool for qualitative studies by the Joanna Briggs Institute and another for quantitative studies by the Centre for Evidence-Based Management were used in the present study. A recent checklist to classify barriers and enablers to health professionals’ adherence to evidence-based practice was also used.

Results

Ten studies met the inclusion criteria out of a total of 9832 search results. The main barriers or enablers identified included poor organisational or institutional level support, health professionals’ limited skills or competence to use a particular therapy, low level of awareness, familiarity or confidence in the effectiveness of a particular evidence-based therapy, limited medical facilities to support evidence uptake, inadequate peer support among health professionals’, complex nature of some stroke care therapies or guidelines and patient level barriers.

Conclusions

Despite considerable evidence supporting various specific therapies for stroke care, uptake of these therapies is compromised by barriers across organisational, patients, guideline interventions and health professionals’ domains. As a result, we recommend that future interventions and health policy directions should be informed by these findings in order to optimise uptake of best practice acute stroke care. Further studies from low- to middle-income countries are needed to understand the barriers and enablers in such settings.

Trial registration

The review protocol was registered in the international prospective register of systematic reviews, PROSPERO 2015 (Registration Number: CRD42015023481)
Appendix
Available only for authorised users
Literature
1.
Cochrane A. Effectiveness and efficiency: Random reflections on health services. London: Nuffield Provincial Hospitals Trust; 1972.
2.
Grol R, Wensing M, Eccles M, Davis D. Improving patient care: the implementation of change in health care: John Wiley & Sons; 2013.
3.
Straus S, Tetroe J, Graham ID. Knowledge translation in health care: moving from evidence to practice: John Wiley & Sons; 2013.
4.
Grimshaw J, Eccles M, Thomas R, MacLennan G, Ramsay C, Fraser C, et al. Toward Evidence‐Based Quality Improvement. J Gen Intern Med. 2006;21(S2):S14–20.PubMedPubMedCentral
5.
World Health Organisation. Research for Universal Health Coverage. Geneva: WHO; 2013.
6.
Dopson S, Locock L, Gabbay J, Ferlie E, Fitzgerald L. Evidence-based medicine and the implementation gap. Health. 2003;7(3):311–30.CrossRef
7.
Grol R, Grimshaw J. From best evidence to best practice: effective implementation of change in patients’ care. Lancet. 2003;362(9391):1225–30.CrossRefPubMed
8.
Morris ZS, Wooding S, Grant J. The answer is 17 years, what is the question: understanding time lags in translational research. J R Soc Med. 2011;104(12):510–20.CrossRefPubMedPubMedCentral
9.
Cabana MD, Rand CS, Powe NR, Wu AW, Wilson MH, Abboud P-AC, et al. Why don’t physicians follow clinical practice guidelines?: A framework for improvement. JAMA. 1999;282(15):1458–65.CrossRefPubMed
10.
11.
Baker R, Camosso-Stefinovic J, Gillies C, Shaw EJ, Cheater F, Flottorp S, et al. Tailored interventions to overcome identified barriers to change: effects on professional practice and health care outcomes. Cochrane Database Syst Rev. 2010;3(3).
12.
Cochrane LJ, Olson CA, Murray S, Dupuis M, Tooman T, Hayes S. Gaps between knowing and doing: understanding and assessing the barriers to optimal health care. J Contin Educ Health Prof. 2007;27(2):94–102.CrossRefPubMed
13.
SURE Collaboration. SURE Guides for Preparing and Using Evidence-Based Policy Briefs: 5 Identifying and addressing barriers to implementing policy options. 2011.
14.
Harvey G, Kitson A. Translating evidence into healthcare policy and practice: Single versus multi-faceted implementation strategies–is there a simple answer to a complex question? Int J Health Policy Manag. 2015;4(3):123.CrossRefPubMedPubMedCentral
15.
Norrving B. Oxford Textbook of Stroke and Cerebrovascular Disease: Oxford University Press; 2014.
16.
World Health Organization. Neurological disorders: public health challenges: World Health Organization; 2006.
17.
Wright L, Hill KM, Bernhardt J, Lindley R, Ada L, Bajorek BV, et al. Stroke management: updated recommendations for treatment along the care continuum. Intern Med J. 2012;42(5):562–9.CrossRefPubMed
18.
Trialists’Collaboration SU. Organised inpatient (stroke unit) care for stroke. Cochrane Database Syst Rev. 2013(4).
19.
Langhorne P, Williams BO, Gilchrist W, Howie K. Do stroke units save lives? Lancet. 1993;342(8868):395–8.CrossRefPubMed
20.
Wardlaw JM MV, Berge E, del Zoppo GJ,. Thrombolysis for acute ischaemic stroke. Cochrane Database of Syst Rev 2014. 2014;Issue 7.
21.
Hacke W, Kaste M, Bluhmki E, Brozman M, Dávalos A, Guidetti D, et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med. 2008;359(13):1317–29.CrossRefPubMed
22.
NINDS. The National Institute of Neurological Disorders and Stroke Study Group. N Engl J Med. 1995;333:1581–7.
23.
Sandercock P, Counsell C, Tseng M, Cecconi E. Oral antiplatelet therapy for acute ischaemic stroke (Review). Cochrane Database Syst Rev. 2014(3).
24.
Collaboration AT. Collaborative overview of randomised trials of antiplatelet therapy Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. BMJ. 1994;308(6921):81–106.CrossRef
25.
Group ISTC. The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19 435 patients with acute ischaemic stroke. Lancet. 1997;349(9065):1569–81.CrossRef
26.
Vahedi K, Hofmeijer J, Juettler E, Vicaut E, George B, Algra A, et al. Early decompressive surgery in malignant infarction of the middle cerebral artery: a pooled analysis of three randomised controlled trials. Lancet Neurol. 2007;6(3):215–22.CrossRefPubMed
27.
Cruz‐Flores S, Berge E, Whittle IR. Surgical decompression for cerebral oedema in acute ischaemic stroke. The Cochrane Library. 2012.
28.
National Institute for Health and Clinical Excellence. Diagnosis and initial management of acute stroke and transient ischaemic attack (TIA). London: Nation Collaborating Centre for Chronic Conditions; 2008. Report No.: 1860163394.
29.
National Stroke Foundation. Clinical guidelines for stroke management 2010. Victoria: National Stroke Foundation; 2010.
30.
Casaubon LK, Boulanger JM, Blacquiere D, Boucher S, Brown K, Goddard T, et al. Canadian stroke best practice recommendations: hyperacute stroke care guidelines, update 2015. Int J Stroke. 2015;10(6):924–40.CrossRefPubMed
31.
Jauch EC, Saver JL, Adams HP, Bruno A, Demaerschalk BM, Khatri P, et al. Guidelines for the early management of patients with acute ischemic stroke a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2013;44(3):870–947.CrossRefPubMed
32.
Steiner T, Al‐Shahi Salman R, Beer R, Christensen H, Cordonnier C, Csiba L, et al. European Stroke Organisation (ESO) guidelines for the management of spontaneous intracerebral hemorrhage. Int J Stroke. 2014;9(7):840–55.CrossRefPubMed
33.
Intercollegiate Stroke Working Party. National clinical guideline for stroke. 4th ed. London: Royal College of Physicians; 2012.
34.
Hemphill JC, Greenberg SM, Anderson CS, Becker K, Bendok BR, Cushman M, et al. Guidelines for the management of spontaneous intracerebral hemorrhage. Stroke. 2015;46(7):2032–60.CrossRefPubMed
35.
Berkowitz AL, Mittal MK, McLane HC, Shen GC, Muralidharan R, Lyons JL, et al. Worldwide reported use of IV tissue plasminogen activator for acute ischemic stroke. Int J Stroke. 2014;9(3):349–55.CrossRefPubMed
36.
Langhorne P, de Villiers L, Pandian JD. Applicability of stroke-unit care to low-income and middle-income countries. Lancet Neurol. 2012;11(4):341–8.CrossRefPubMed
37.
Norrving B, Kissela B. The global burden of stroke and need for a continuum of care. Neurology. 2013;80(3 Suppl 2):S5–12.CrossRefPubMed
38.
Baatiema L, Otim M, Mnatzaganian G, Aikins AD-G, Coombes J, Somerset S. Towards best practice in acute stroke care in Ghana: a survey of hospital services. BMC Health Serv Res. 2017;17(1):108.CrossRefPubMedPubMedCentral
39.
Dale S, Levi C, Ward J, Grimshaw JM, Jammali-Blasi A, D’Este C, et al. Barriers and Enablers to Implementing Clinical Treatment Protocols for Fever, Hyperglycaemia, and Swallowing Dysfunction in the Quality in Acute Stroke Care (QASC) Project-A Mixed Methods Study. Worldviews Evid-Based Nurs. 2015;12(1):41–50.CrossRefPubMed
40.
Donnellan C, Sweetman S, Shelley E. Health professionals’ adherence to stroke clinical guidelines: a review of the literature. Health Policy. 2013;111(3):245–63.CrossRefPubMed
41.
Kwan J, Hand P, Sandercock P. A systematic review of barriers to delivery of thrombolysis for acute stroke. Age Ageing. 2004;33(2):116–21.CrossRefPubMed
42.
Sandercock P, Berge E, Dennis M, Forbes J, Hand P, Kwan J, et al. A systematic review of the effectiveness, cost-effectiveness and barriers to implementation of thrombolytic and neuroprotective therapy for acute ischaemic stroke in the NHS. Health Technol Assess (Winchester, England). 2001;6(26):1–112.
43.
Eissa A, Krass I, Bajorek B. Barriers to the utilization of thrombolysis for acute ischaemic stroke. J Clin Pharm Ther. 2012;37(4):399–409.CrossRefPubMed
44.
Johnson M, Bakas T. A review of barriers to thrombolytic therapy: Implications for nursing care in the emergency department. J Neurosci Nurs. 2010;42(2):88–94.CrossRefPubMed
45.
Sandercock P, Berge E, Dennis M, Forbes J, Hand P, Kwan J, et al. A systematic review of the effectiveness, cost-effectiveness and barriers to implementation of thrombolytic and neuroprotective therapy for acute ischaemic stroke in the NHS. Health Technol Assess. 2002;6(26):1–112.CrossRefPubMed
46.
Baatiema L, De-Graft Aikins A, Sav A, Mnatzaganian G, Chan CKY. Somerset S. Barriers to evidence-based acute stroke care in Ghana: A qualitative study on the perspectives of stroke care professionals. BMJ Open. 2017;7(4):e015385. doi:10.​1136/​bmjopen-2016-015385.
47.
48.
Craig LE, McInnes E, Taylor N, Grimley R, Cadilhac DA, Considine J, et al. Identifying the barriers and enablers for a triage, treatment, and transfer clinical intervention to manage acute stroke patients in the emergency department: a systematic review using the theoretical domains framework (TDF). Implement Sci. 2016;11(1):157.CrossRefPubMedPubMedCentral
49.
Feigin VL, Lawes CM, Bennett DA, Barker-Collo SL, Parag V. Worldwide stroke incidence and early case fatality reported in 56 population-based studies: a systematic review. Lancet Neurol. 2009;8(4):355–69.CrossRefPubMed
50.
Johnston SC, Mendis S, Mathers CD. Global variation in stroke burden and mortality: estimates from monitoring, surveillance, and modelling. Lancet Neurol. 2009;8(4):345–54.CrossRefPubMed
51.
Feigin VL, Roth GA, Naghavi M, Parmar P, Krishnamurthi R, Chugh S, et al. Global burden of stroke and risk factors in 188 countries, during 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet Neurol. 2016.
52.
Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 2009;151(4):264–9.CrossRefPubMed
53.
Dopson S, Fitzgerald L. Knowledge to action?: evidence-based health care in context. Oxford: Oxford University Press; 2005.CrossRef
54.
Wensing M, Oxman A, Baker R, Godycki-Cwirko M, Flottorp S, Szecsenyi J, et al. Tailored implementation for chronic diseases (TICD): a project protocol. Implement Sci. 2011;6(1):103.CrossRefPubMedPubMedCentral
55.
Flottorp SA, Oxman AD, Krause J, Musila NR, Wensing M, Godycki-Cwirko M, et al. A checklist for identifying determinants of practice: a systematic review and synthesis of frameworks and taxonomies of factors that prevent or enable improvements in healthcare professional practice. Implement Sci. 2013;8(1):35.CrossRefPubMedPubMedCentral
56.
Joanna Briggs Institute. Systematic Review Resource Package. Adelaide: The Joanna Briggs Institute; 2015.
57.
58.
Dixon-Woods M, Bonas S, Booth A, Jones DR, Miller T, Sutton AJ, et al. How can systematic reviews incorporate qualitative research? A critical perspective. Qual Res. 2006;6(1):27–44.CrossRef
59.
Atkins S, Lewin S, Smith H, Engel M, Fretheim A, Volmink J. Conducting a meta-ethnography of qualitative literature: lessons learnt. BMC Med Res Methodol. 2008;8(1):21.CrossRefPubMedPubMedCentral
60.
Meurer WJ, Majersik JJ, Frederiksen SM, Kade AM, Sandretto AM, Scott PA. Provider perceptions of barriers to the emergency use of tPA for acute ischemic stroke: a qualitative study. BMC Emerg Med. 2011;11(1):5.CrossRefPubMedPubMedCentral
61.
Stecksén A, Lundman B, Eriksson M, Glader E-L, Asplund K. Implementing Thrombolytic Guidelines in Stroke Care Perceived Facilitators and Barriers. Qual Health Res. 2013:1049732313514137.
62.
Purvis T, Moss K, Denisenko S, Bladin C, Cadilhac DA. Implementation of evidence-based stroke care: enablers, barriers, and the role of facilitators. J Multidiscip Healthc. 2014;7:389.PubMedPubMedCentral
63.
Chan Y-F, Kwiatkowski TG, Rella JG, Rennie WP, Kwon RK, Silverman RA. Tissue plasminogen activator for acute ischemic stroke: a New York city emergency medicine perspective. J Emerg Med. 2005;29(4):405–8.CrossRefPubMed
64.
Grady A, Bryant J, Carey M, Paul C, Sanson-Fisher R. Enablers of the Implementation of Tissue Plasminogen Activator in Acute Stroke Care: A Cross-Sectional Survey. PLoS One. 2014;9(12):e114778.CrossRefPubMedPubMedCentral
65.
Hargis M, Shah JN, Mazabob J, Rao CV, Suarez JI, Bershad EM. Barriers to administering intravenous tissue plasminogen activator (tPA) for acute ischemic stroke in the emergency department: A cross-sectional survey of stroke centers. Clin Neurol Neurosurg. 2015;135:79–84.CrossRefPubMed
66.
O’Rourke F, Chan DKY, Chan DL, Ding XM. Preferences, barriers and facilitators for establishing comprehensive stroke units: a multidisciplinary survey. Aust Health Rev. 2013;37(3):318–23.PubMed
67.
Slot KB, Murray V, Boysen G, Berge E. Thrombolytic treatment for stroke in the Scandinavian countries. Acta Neurol Scand. 2009;120(4):270–6.CrossRefPubMed
68.
Van Der Weijden T, Hooi JD, Grol R, Limburg M. A multidisciplinary guideline for the acute phase of stroke: barriers perceived by Dutch neurologists. J Eval Clin Pract. 2004;10(2):241–6.CrossRef
69.
Williams JM, Jude MR, Levi CR. Recombinant tissue plasminogen activator (rt‐PA) utilisation by rural clinicians in acute ischaemic stroke: A survey of barriers and enablers. Aust J Rural Health. 2013;21(5):262–7.CrossRefPubMed
70.
Ehlers L, Jensen LG, Bech MA, Andersen G, Kjølby M. Organisational barriers to thrombolysis treatment of acute ischaemic stroke. Curr Med Res Opin. 2007;23(11):2833–9.CrossRefPubMed
71.
Donnellan C, Sweetman S, Shelley E. Implementing clinical guidelines in stroke: a qualitative study of perceived facilitators and barriers. Health Policy. 2013;111(3):234–44.CrossRefPubMed
72.
73.
Dombrowski SU, Mackintosh JE, Sniehotta FF, Araujo-Soares V, Rodgers H, Thomson RG, et al. The impact of the UK ‘Act FAST’stroke awareness campaign: content analysis of patients, witness and primary care clinicians’ perceptions. BMC Public Health. 2013;13(1):915.CrossRefPubMedPubMedCentral
74.
Mellon L, Hickey A, Doyle F, Dolan E, Williams D. Can a media campaign change health service use in a population with stroke symptoms? Examination of the first Irish stroke awareness campaign. Emerg Med J. 2014;31(7):536–40.CrossRefPubMed
75.
76.
77.
Brainin M, Teuschl Y, Kalra L. Acute treatment and long-term management of stroke in developing countries. Lancet Neurol. 2007;6(6):553–61.CrossRefPubMed
78.
Thrift AG, de los Rios F. Expanding antiplatelet use for patients with stroke The case for stroke of unknown type. Neurology. 2014;83(9):778–9.CrossRefPubMed
79.
80.
Lewin S, Glenton C, Munthe-Kaas H, Carlsen B, Colvin CJ, Gülmezoglu M, et al. Using qualitative evidence in decision making for health and social interventions: an approach to assess confidence in findings from qualitative evidence syntheses (GRADE-CERQual). PLoS Med. 2015;12(10):e1001895.CrossRefPubMedPubMedCentral
Metadata
Title
Health professionals’ views on the barriers and enablers to evidence-based practice for acute stroke care: a systematic review
Authors
Leonard Baatiema
Michael E. Otim
George Mnatzaganian
Ama de-Graft Aikins
Judith Coombes
Shawn Somerset
Publication date
01-12-2017
Publisher
BioMed Central
Published in
Implementation Science / Issue 1/2017
Electronic ISSN: 1748-5908
DOI
https://doi.org/10.1186/s13012-017-0599-3

Other articles of this Issue 1/2017

Implementation Science 1/2017 Go to the issue

Study protocol

Evaluation of the Tsima community mobilization intervention to improve engagement in HIV testing and care in South Africa: study protocol for a cluster randomized trial

Debate

Community-based participatory research and integrated knowledge translation: advancing the co-creation of knowledge

Study protocol

Provision of peer specialist services in VA patient aligned care teams: protocol for testing a cluster randomized implementation trial

Systematic review

Using media to impact health policy-making: an integrative systematic review

Research

Advancing theory development: exploring the leadership–climate relationship as a mechanism of the implementation of cultural competence

Study protocol

Electronic Laboratory Medicine ordering with evidence-based Order sets in primary care (ELMO study): protocol for a cluster randomised trial